EraCal Therapeutics AG’s €235 Million Licensing Agreement To Novo Nordisk

VISCHER advised EraCal on all legal issues related to the transaction.EraCal Therapeutics has signed a collaboration and license agreement with Danish pharma producer Novo Nordisk. According…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Marco Zingaro

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here